<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Q</submitter><funding>National Natural Science Foundation of China (Young Scientists Fund)</funding><funding>Guangxi Science and Technology Base and Talent Special Project</funding><funding>Innovation Project of Guangxi Graduate Education of GXUCM</funding><funding>National Natural Science Foundation of China</funding><pagination>4649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11805973</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Jiawei Chaihu Shugan decoction (JWCHSGD) is a traditional Chinese medicine well-known for its beneficial effects in treating epilepsy (Xianzheng in ancient Chinese), but the molecular mechanism of its action remains unclear. To investigate the molecular mechanism of JWCHSGD's prevention of epilepsy-mediated neuron from necroptosis and inflammation via the circRNA-Csnk1g3/Csnk1g3-85aa/ CK1γ3/TNF-α signal pathway. In vitro, murine neuronal HT22 cells were treated in six groups: control, model, carbamazepine, and three JWCHSGD doses (high, medium, low). Viability and apoptosis were assessed via CCK-8 and flow cytometry. In vivo, 60 C57BL/6J mice were divided into six groups: control, model, carbamazepine, JWCHSGD, JWCHSGD + Sh Circ_Csnk1g3, and JWCHSGD + Sh NC. An epilepsy model was induced, </pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Mitigating effects of Jiawei Chaihu Shugan decoction on necroptosis and inflammation of hippocampal neurons in epileptic mice.</pubmed_title><pmcid>PMC11805973</pmcid><funding_grant_id>GUI KE AD22035168</funding_grant_id><funding_grant_id>82360875</funding_grant_id><funding_grant_id>82405356</funding_grant_id><funding_grant_id>YCBXJ2023005</funding_grant_id><pubmed_authors>Zeng R</pubmed_authors><pubmed_authors>Diao L</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Fan J</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zeng J</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Qin B</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitigating effects of Jiawei Chaihu Shugan decoction on necroptosis and inflammation of hippocampal neurons in epileptic mice.</name><description>Jiawei Chaihu Shugan decoction (JWCHSGD) is a traditional Chinese medicine well-known for its beneficial effects in treating epilepsy (Xianzheng in ancient Chinese), but the molecular mechanism of its action remains unclear. To investigate the molecular mechanism of JWCHSGD's prevention of epilepsy-mediated neuron from necroptosis and inflammation via the circRNA-Csnk1g3/Csnk1g3-85aa/ CK1γ3/TNF-α signal pathway. In vitro, murine neuronal HT22 cells were treated in six groups: control, model, carbamazepine, and three JWCHSGD doses (high, medium, low). Viability and apoptosis were assessed via CCK-8 and flow cytometry. In vivo, 60 C57BL/6J mice were divided into six groups: control, model, carbamazepine, JWCHSGD, JWCHSGD + Sh Circ_Csnk1g3, and JWCHSGD + Sh NC. An epilepsy model was induced, </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T02:43:37.852Z</modification><creation>2025-04-04T02:43:37.852Z</creation></dates><accession>S-EPMC11805973</accession><cross_references><pubmed>39920301</pubmed><doi>10.1038/s41598-025-89275-8</doi></cross_references></HashMap>